The experimental results are promising and the proposed prediction model is expected to achieve even higher classification accuracy in identifying the presence of prostate cancer in asymptomatic individuals with PSA levels < 20 ng ml-1 based on peripheral blood NK cell phenotypic profiles as more data become available in the future. This evidence concerns the gene KLK3 and prostate cancer.